KCNE5

KCNE5 is an X-linked auxiliary β-subunit of voltage-gated potassium channels that modulates cardiac repolarization by inhibiting multiple Kv α-subunits. It coassembles with KCNQ1 and shifts its voltage activation by >140 mV in the depolarizing direction through four critical transmembrane-domain residues, and it suppresses IKs (KCNQ1/KCNE1) current in a concentration-dependent manner (PMID:12324418, PMID:18313602). KCNE5 also associates with Kv2.1, promoting its intracellular vesicular sequestration to reduce IKslow,2, and modulates Kv4.3-mediated Ito; Kcne5 knockout in mice increases ventricular Kv current density across multiple channel subtypes (PMID:30289750, PMID:21493962). Loss-of-function mutations in KCNE5 (e.g., L65F) abolish IKs suppression and augment Kv2.1 current, predisposing to atrial fibrillation, while gain-of-function variants (Y81H, D92E;E93X) augment Ito and are linked to Brugada syndrome (PMID:18313602, PMID:21493962, PMID:30289750).

1. 2002 High

   Establishing that KCNE5 is a KCNQ1-specific modulatory subunit resolved the question of whether this orphan β-subunit had a defined channel partner and revealed an unusually large (~140 mV) positive shift in voltage activation as its primary inhibitory mechanism.

   Evidence Voltage-clamp electrophysiology in Xenopus oocytes and mammalian cells with transmembrane-domain mutagenesis

   PMID:12324418

   Open questions at the time

   • Whether KCNE5 modulates channels beyond the KCNQ and hERG families was untested
   • Physiological relevance of the inhibition in native cardiomyocytes was not demonstrated
   • Stoichiometry of the KCNQ1–KCNE5 complex was not determined
2. 2008 High

   Demonstrating that KCNE5 suppresses IKs in a concentration-dependent manner and that the AF-associated L65F mutation abolishes this suppression linked KCNE5 loss-of-function directly to a disease-relevant gain of IKs current.

   Evidence Whole-cell patch-clamp of CHO cells coexpressing KCNQ1/KCNE1 with wild-type or L65F KCNE5 at varying ratios

   PMID:18313602

   Open questions at the time

   • Whether L65F affects KCNE5 trafficking or assembly rather than gating modulation was not resolved
   • No in vivo or native tissue confirmation of IKs augmentation by the L65F variant
3. 2011 High

   Showing that KCNE5 variants Y81H and D92E;E93X selectively augment Kv4.3-mediated Ito without altering KCNQ1 current established KCNE5 as a multipartner β-subunit and connected gain-of-function Ito to Brugada syndrome pathogenesis.

   Evidence Patch-clamp electrophysiology of KCND3 or KCNQ1 coexpressed with mutant KCNE5, complemented by action-potential simulation

   PMID:21493962

   Open questions at the time

   • Direct physical interaction between KCNE5 and Kv4.3 was not demonstrated by biochemical methods
   • Whether the Ito augmentation involves KChIP accessory subunits present in native cardiomyocytes was unknown
4. 2018 High

   Kcne5 knockout mice revealed that KCNE5 tonically suppresses multiple ventricular Kv currents (IKslow,1, Ito,f, IKslow,2) in vivo, and that the mechanism for Kv2.1 inhibition involves promoting intracellular sequestration rather than solely altering gating.

   Evidence Kcne5-null mice with intracardiac ECG, patch-clamp on isolated ventricular myocytes, immunofluorescence colocalization in cardiac and HEK293 cells, and heterologous expression of L65F mutant with Kv2.1

   PMID:30289750

   Open questions at the time

   • Atrial electrophysiology in the knockout was not characterized, leaving the AF-relevant substrate undefined
   • Molecular mechanism by which KCNE5 promotes Kv2.1 vesicular retention is unknown
   • Whether KCNE5 directly binds Kv1.5 or acts indirectly was not resolved

• The structural basis of KCNE5 interactions with its multiple Kv α-subunit partners, the stoichiometry of these complexes, and the precise trafficking mechanism by which KCNE5 retains Kv2.1 intracellularly remain unresolved.
• No high-resolution structure of any KCNE5-containing channel complex exists
• Subunit stoichiometry for KCNE5 with KCNQ1, Kv4.3, or Kv2.1 has not been determined
• Atrial-specific roles of KCNE5 have not been tested in conditional knockout models